Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for chronic depression: Clinical characteristics and six month clinical outcomes in an open case series.

被引:16
|
作者
Swan, John S. [1 ]
MacVicar, Robert [2 ,3 ]
Christmas, David [2 ,3 ]
Durham, Rob [2 ,3 ]
Rauchhaus, Petra [4 ]
McCullough, James P., Jr. [5 ]
Matthews, Keith [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Neurosci, Dundee DD1 9SY, Scotland
[2] NHS Tayside, Adv Intervent Serv, Dundee DD1 9SY, Scotland
[3] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland
[4] Univ Dundee, Med Res Inst, Dundee Epidemiol & Biostat Unit, Div Populat Hlth Sci, Dundee DD1 9SY, Scotland
[5] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA
关键词
Case series; Chronic depression; CBASP; Psychotherapy; Treatment refractory; CHRONIC MAJOR DEPRESSION; CHRONIC FORMS; DSM-IV; DISORDERS; ONSET; CLASSIFICATION; COMBINATION; DYSTHYMIA; VALIDITY; BURDEN;
D O I
10.1016/j.jad.2013.09.024
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Evidence-based guidance on how best to treat chronic depression is limited. Cognitive Behavioural Analysis System of Psychotherapy (CBASP) has shown some promise with this 'difficult-to-treat' clinical group. This case series was designed to assess the acceptability and utility of this novel treatment in routine clinical practice within the U.K. National Health Service. Methods: We offered an open trial of CBASP to a cohort of 115 referred patients within primary and secondary care. Diagnostic interview and standardised outcome measures were administered before and after 6 months of CBASP with a trained, accredited therapist. Results: Seventy-four patients entered therapy, with 46 completing. 30% met criteria for remission (<= 8 HRSD-24 score) and a further 30% met criteria for clinically significant change (> 8 and <= 15 HRSD-24 plus 50% reduction in baseline score). Thirty-nine per cent made "No change". Group measures of quality of life, social functioning and interpersonal functioning also improved. Limitations: This was an open study design with a moderate sample size and no control group. Ratings were not completed using a blinded procedure. Conclusions: CBASP is an acceptable therapy for a large proportion of patients with chronic depression and was associated with clinically significant change in 60% of completers. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:268 / 276
页数:9
相关论文
共 38 条